Abdominal compartment syndrome (ACS) occurs when sustained high intra-abdominal pressure (>20 mmHg) causes organ dysfunction. It is increasingly recognized in critically ill patients and can lead to multi-organ failure if not treated. Intra-abdominal pressure is normally 5-7 mmHg but becomes a concern above 12 mmHg and dangerous above 20 mmHg. Causes include abdominal bleeding, edema from fluid resuscitation, and abdominal wall closure under tension. Early detection by bladder pressure monitoring and treatment by optimizing abdominal perfusion pressure can prevent progression to ACS and improve outcomes. Decompressive laparotomy may be needed for refractory cases.
Approach to Management of Upper Gastrointestinal (GI) BleedingArun Vasireddy
Upper gastrointestinal bleeding is gastrointestinal bleeding in the upper gastrointestinal tract, commonly defined as bleeding arising from the esophagus, stomach, or duodenum. Blood may be observed in vomit (hematemesis) or in altered form in the stool (melena). Depending on the severity of the blood loss, there may be symptoms of insufficient circulating blood volume and shock. As a result, upper gastrointestinal bleeding is considered a medical emergency and typically requires hospital care for urgent diagnosis and treatment. Upper gastrointestinal bleeding can be caused by peptic ulcers, gastric erosions, esophageal varices, and some rarer causes such as gastric cancer.
The initial assessment includes measurement of the blood pressure and heart rate, as well as blood tests to determine hemoglobin concentration. In significant bleeding, fluid replacement is often required, as well as blood transfusion, before the source of bleeding can be determined by endoscopy of the upper digestive tract with an esophagogastroduodenoscopy. Depending on the source, endoscopic therapy can be applied to reduce rebleeding risk. Specific medical treatments (such as proton pump inhibitors for peptic ulcer disease) or procedures (such as TIPS for variceal hemorrhage) may be used. Recurrent or refractory bleeding may lead to need for surgery, although this has become uncommon as a result of improved endoscopic and medical treatment.
Splenic trauma - Causes, Complications, ManagementVikas V
Splenic Trauma - A detailed Presentation about Splenic Trauma, anatomy of the spleen, Causes of Trauma, Mechanism of Injury, Diagnosis, Management, Surgical management, Steps of Splenectomy, and Complications
Approach to Management of Upper Gastrointestinal (GI) BleedingArun Vasireddy
Upper gastrointestinal bleeding is gastrointestinal bleeding in the upper gastrointestinal tract, commonly defined as bleeding arising from the esophagus, stomach, or duodenum. Blood may be observed in vomit (hematemesis) or in altered form in the stool (melena). Depending on the severity of the blood loss, there may be symptoms of insufficient circulating blood volume and shock. As a result, upper gastrointestinal bleeding is considered a medical emergency and typically requires hospital care for urgent diagnosis and treatment. Upper gastrointestinal bleeding can be caused by peptic ulcers, gastric erosions, esophageal varices, and some rarer causes such as gastric cancer.
The initial assessment includes measurement of the blood pressure and heart rate, as well as blood tests to determine hemoglobin concentration. In significant bleeding, fluid replacement is often required, as well as blood transfusion, before the source of bleeding can be determined by endoscopy of the upper digestive tract with an esophagogastroduodenoscopy. Depending on the source, endoscopic therapy can be applied to reduce rebleeding risk. Specific medical treatments (such as proton pump inhibitors for peptic ulcer disease) or procedures (such as TIPS for variceal hemorrhage) may be used. Recurrent or refractory bleeding may lead to need for surgery, although this has become uncommon as a result of improved endoscopic and medical treatment.
Splenic trauma - Causes, Complications, ManagementVikas V
Splenic Trauma - A detailed Presentation about Splenic Trauma, anatomy of the spleen, Causes of Trauma, Mechanism of Injury, Diagnosis, Management, Surgical management, Steps of Splenectomy, and Complications
Intra-abdominal hypertension and abdominal compartment syndromeNicholas Leary
Intra-abdominal hypertension and abdominal compartment syndrome is equally as prevalent in the medical population as the trauma population. Learn about the pathophysiology, how to monitor, and treatment for IAH and ACS.
This presentation deals with the causes, signs, symptoms and management of compartment syndrome. It also briefly deals with abdominal comaprtment syndrome
This updated encyclopaedia of anaesthesia and intensive care medicine covers aspects relating to Anesthesia & critical care medicine. With extensive line diagrams & topic descriptions, this is a reference title that every post graduate should own.
If you would like to purchase this title, please visit Elsevier Asia Bookshop.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
3. Definitions
A. Intra-abdominal Pressure (IAP): Intrinsic pressure within
the abdominal cavity most critically ill patients, an IAP of 5 to
7 mmHg is considered normal, obese and pregnant
individuals may have chronically higher baseline IAP (as
high as 10 to 15 mmHg) without adverse sequelae.
B. Abdominal perfusion pressure (APP): APP =MAP - IAP
Elevated IAP reduces blood flow to the abdominal viscera. A
target APP of at least 60 mmHg is correlated with improved
survival from IAH and ACS. was found to be better than
other resuscitation endpoints e.g. hourly urinary output for
predicting the outcomes.
C. Intra-abdominal Hypertension (IAH): An IAP > 12 mm Hg
(often causing occult ischemia) without obvious organ failure
D. Abdominal Compartment Syndrome (ACS): A sustained
IAP >20 mmHg (with or without APP <60 mmHg) that is
associated with new organ dysfunction.
4. What intra-abdominal pressures are
concerning?
Pressure (mm Hg) Interpretation
0-5 Normal
10-15 Obese and pregnant chronically
high baseline
5-10 Common in most ICU patients
> 12 Intra-abdominal hypertension
15-20 Dangerous IAH - consider non-
invasive interventions
>20-25 Impending abdominal compartment
syndrome - strongly consider
decompressive laparotomy
5.
6. Intraabdominal Hypertension
Hyperacute IAH: lasting only seconds.laughing, coughing,
straining, sneezing, defecation, or physical activity. IAH with
gastric over-distention following endoscopy.
Acute IAH: Develops over hours,trauma or intraabdominal
hemorrhage and can lead to the rapid development of ACS.
Subacute IAH : Develops over days. most common in medical
patients and can also lead to ACS.
Chronic IAH: Develops over months (pregnancy) or years
(morbid obesity). It does not cause ACS, but does place the
individual at higher risk for ACS if they develop superimposed
acute or subacute IAH.
Grade I = IAP 12 to 15 mmHg
Grade II = IAP 16 to 20 mmHg
Grade III = IAP 21 to 25 mmHg
7.
8. Causes of Intra-abdominal Pressure (IAP) Elevation
Retroperitoneal: pancreatitis, retroperitoneal or pelvic
bleeding, contained AAA rupture, aortic surgery,
abscess, visceral edema
Intraperitoneal: intraperitoneal bleeding, AAA rupture,
acute gastric dilatation, bowel obstruction, ileus,
mesenteric venous obstruction, pneumoperitoneum,
abdominal packing, abscess, visceral edema
secondary to resuscitation (SIRS)
Abdominal Wall: burn eschar, repair of gastroschisis or
omphalocele, reduction of large hernias, pneumatic
anti-shock garments, lap closure under tension,
abdominal binders
Chronic: central obesity, ascites, large abdominal
9. Intra-Abdominal Pressure Monitoring
IAP can be measured indirectly using:
1. intragastric
2. intracolonic
3. intravesical (bladder)
4. inferior vena cava catheters
Measurement of bladder (ie, intravesical) pressure is the
standard method to screen for IAH and ACS. It is simple,
minimally invasive, and accurate.
11. Physiologic Sequelae:
Elevated intra-abdominal
pressure causes:
•Reduces perfusion of
surgical and traumatic
wounds
•Reduced blood flow to liver,
bone marrow, etc.
•Blood pooling in pelvis and
legs
•“Second hit” in the two
event model of MOF?
The Result:
Poor wound healing and
dehiscence
Coagulopathy
Immunosuppression
DVT and PE risks
13. Clinical presentation
It is desirable to recognize IAH early, so it can be treated before
progressing to ACS.
Symptoms:
Most patients critically ill and unable to communicate.
symptoms may complain of malaise, weakness,
lightheadedness, dyspnea, abdominal bloating, or abdominal
pain.
Physical signs:
Tensely distended abdomen,the abdomen is a poor predictor
of ACS, Progressive oliguria.
Other findings may include hypotension, tachycardia, an
elevated jugular venous pressure, jugular venous distension,
peripheral edema, abdominal tenderness, or acute
pulmonary decompensation.
There may also be evidence of hypoperfusion, including cool
14. Imaging findings:
- Imaging is not helpful in the diagnosis of ACS.
- CXR may show decreased lung volumes,
atelectasis, or elevated hemidiaphragms.
- Computed tomography (CT) may demonstrate tense
infiltration of the retroperitoneum that is out of
proportion to peritoneal disease, extrinsic compression
of the inferior vena cava, massive abdominal
distention, direct renal compression or displacement,
bowel wall thickening, or bilateral inguinal herniation.
15. How common is this syndrome?
Malbrain, Intensive Care Medicine (2004)
Abdominal
pressure:
Total
Prevalence
MICU
prevalence
SICU
prevalence
IAP > 12 58.8% 54.4% 65%
IAP > 15 28.9% 29.8% 27.5%
IAP > 20
plus organ
failure
8.2% 10.5% 5.0%
16. IAH/ACS Management
Fluids – two edged sword
Fluids will absolutely improve cardiac indices if the
patient has inadequate RV filling- so early in the
course they are necessary
However, over resuscitation will lead to worsened
edema
Abdominal perfusion pressure - optimize fluids first
then add vasopressors. Shoot for a perfusion
pressure > 60 mm Hg
Sedation, Paralytics
Cathaterise / enema to clear bowel?
Colloids
Hemofiltration
Paracentesis
Need significant free fluid on US
Decompressive laparotomy
17. IAH/ACS Management : Abdominal Perfusion
Pressure
APP = MAP - IAP
Abdominal perfusion pressure reflects actual gut
perfusion better than IAP alone.
Optimizing APP to > 60 mm Hg should probably be
primary endpoint
Cheatham 2000
Optimizing APP reduced incidence of
ACS - 64% versus 48%
Death - 44% versus 28%
18. Decompressive Laparotomy and Open
Abdomen
Open abdomen is an abdominal wall defect created by
intentionally leaving an abdominal incision open at the
completion of intraabdominal surgery or by opening (or re-
opening) the abdomen because of concern for abdominal
compartment syndrome.
Complications of open abdomen:
1. Fluid loss :Daily fluid balance and the patient’s fluid
intake should be adjusted to prevent hypovolemia.
2. Protein loss : About 2 grams of protein lost from the
abdomen for each liter of fluid removed.
3. Fistula formation : Entero-cutaneous or entero-
atmospheric fistula may be as high as 20 percent and
can occur as early as eight days from the initial
laparotomy.
19. TEMPORARY ABDOMINAL CLOSURE
Once a decision has been made to leave the abdomen open (or
re-open it), the abdominal defect must be covered, which is
termed temporary abdominal closure.
Techniques:
1. Patch techniques
2. Negative pressure wound systems
3. Towel-based
4. Sponge-based
5. Silo techniques
6. Skin-only closures
Mean rates for primary fascial closure are as follows :
90 percent: Wittmann Patch (4 studies/180 patients)
85 percent: Dynamic fascial closure (1 study/15 patients)
60 percent: Sponge-based negative pressure system
(8 studies/251 patients)
52 percent: Towel-based negative pressure system
(15 studies/1186 patients)
20. ABDOMINAL CLOSURE
1. Fascial closure techniques : Ideal management of the open
abdomen results in closure that brings the edges of the
abdominal fascia together primarily (primary closure). If this is
not feasible, functional closure or simple coverage can be
provided.
2. Primary fascial closure : Primary closure of the fascia refers
to the direct approximation of the fascial edges to each other
and is associated with the lowest rate of complications.
incidence of ventral hernia chances 30%.
3. Functional closure : Functional closure refers to the bridging
of a residual fascial defect with a biologic mesh.
4. Planned ventral hernia: If primary fascial closure or
functional closure cannot be achieved, then planned ventral
hernia is the only option. . Skin coverage over abdominal
viscera can be accomplished in one of two ways:
Skin-only closure
21. Patient outcome?
Ivatury, J Trauma, 1998:
70 patients with monitored for IAP > 25 mm Hg
25 had fascial closure at time of surgery:
52% developed IAP > 25
39% Died
45 cases had abdomen left “open”:
22% developed IAP > 25
10.6% Died
22. Final Thought
Do NOT wait for signs of ACS to be present before
you decide to check IAP
By then the patient has one foot in the grave!
You have lost your opportunity for medical therapy
Monitor ALL high risk patients early and often:
TREND IAP like a vital sign
Intervene early, before critical pressure develops